BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//IACS - ECPv6.15.11//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:IACS
X-ORIGINAL-URL:https://www.iacs.es
X-WR-CALDESC:Eventos para IACS
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Madrid
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20221030T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20231212T080000
DTEND;TZID=Europe/Madrid:20240430T170000
DTSTAMP:20260417T183848
CREATED:20231212T110713Z
LAST-MODIFIED:20231212T110713Z
UID:10002001-1702368000-1714496400@www.iacs.es
SUMMARY:Partenariado Europeo para la Medicina Personalizada (EP PerMed)
DESCRIPTION:Comienza un nuevo Partenariado Europeo para la Medicina Personalizada (EP PerMed) \nEl IACS es parte del nuevo Partenariado Europeo para la Medicina Personalizada (EP PerMed) que pretende mejorar la asistencia sanitaria futura de todos los ciudadanos mediante la personalización de la terapia\, el diagnóstico y la prevención. \nCon un presupuesto total de unos 375 millones de euros y más de 50 socios internacionales\, EP PerMed no sólo apoyará significativamente el desarrollo transnacional de enfoques de medicina personalizada en los próximos diez años\, sino también su traslación con éxito a la práctica clínica. \nEl IACS lidera el paquete de trabajo 4 (WP4) para la implementación de la Medicina Personalizada en los sistemas de Salud. \nEP PerMed ha publicado un anuncio preliminar de la primera convocatoria transnacional conjunta de propuestas con el topic «Identification or Validation of Targets for Personalised Medicine Approaches (PMTargets)». En este enlace se puede encontrar toda la información. \nPara ampliar esta información\, o para cualquier otra consulta\, no dudes en contactar con Elena Portero (eportero.iacs@aragon.es) \n 
URL:https://www.iacs.es/evento/partenariado-europeo-para-la-medicina-personalizada-ep-permed/
LOCATION:San Juan Bosco\, 13\, Zaragoza\, Zaragoza\, 50009\, España
CATEGORIES:Convocatoria internacional
GEO:41.64381;-0.9024
X-APPLE-STRUCTURED-LOCATION;VALUE=URI;X-ADDRESS=San Juan Bosco 13 Zaragoza Zaragoza 50009 España;X-APPLE-RADIUS=500;X-TITLE=San Juan Bosco\, 13:geo:-0.9024,41.64381
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20240110T080000
DTEND;TZID=Europe/Madrid:20240620T170000
DTSTAMP:20260417T183848
CREATED:20240110T105606Z
LAST-MODIFIED:20240110T110336Z
UID:10002005-1704873600-1718902800@www.iacs.es
SUMMARY:EP PerMed Joint Transnational Call 2024
DESCRIPTION:EP PerMed is launching the first Joint Transnational Call (JTC2024) for proposals on “Identification or Validation of Targets for Personalised Medicine Approaches (PMTargets)”. In total\, 39 funding organisations of 24 countries and 10 European national regions participate in this call with a budget of over 45 Mio€. This call is cofunded by the European Union. \nWith its first JTC\, EP PerMed aims to fund research that fosters the identification or validation of targets for personalised medicine (PM) approaches. The overall objectives of the JTC2024 are to \n\nSupport research projects in human health aiming at identifying or validating targets for personalised medicine approaches in combination with development of companion biomarkers or other markers to allow for monitoring of treatment outcomes and patient stratification;\nEncourage and enable interdisciplinary collaborations by combining pre-clinical and clinical research in translational projects\, and multi-actor research by engaging a range of other relevant disciplines such as bioinformatics/health informatics/data research\, ELSA research\, implementation research or health economics research connected to the proposed research topic\, including end-user perspective analysis to empower the implementation of PM; and\nEncourage cross-sectorial collaborations\, by including the private sector (e.g. SMEs\, small and medium-sized enterprises)\, industry\, as well as regulatory/HTA agencies and patient organisations.\n\nThe core of each application must be the identification or validation of a target for personalised medicine approaches in combination with companion biomarker research. In addition\, the consortia can address accompanying research if this is necessary for the identification or validation of the target and if appropriate to the development status of the project. EP PerMed strongly encourages the active involvement of end-users in the proposed research projects. \nDepending on the development phase of the research\, projects can focus on the following stages: \n\nStage 1: Identification of novel targets for the development of a concrete and feasible PM approach\, based on a clearly circumscribed biological/clinical hypothesis\, in combination with companion biomarker research. Applicants are advised to use existing clinical data as a basis for target identification.\nStage 2: Development or validation of already known but not yet established targets for a PM approach\, in combination with accompanying biomarker research. This includes target validation in vitro and in animal models (proof-of-principle studies)\, early pharmacological and toxicity tests and\, if feasible\, exploratory clinical studies to demonstrate clinical applicability (proof-of-concept studies).\n\nExclusion: Research focussing only on new biomarker discovery. Projects submitted to the JTC2024 focussing on the identification of new biomarkers as the sole purpose of the research are out of the scope. \nStages are not mutually exclusive. They define the overall scope of the JTC2024 to which all proposals must comply. \nResearch projects in all disease areas are encouraged. Consortia are required to start from a relevant clinical (unmet) need and to include activities that support a comprehensive and efficient uptake of the developed PM approach in clinical practice\, with the aim that “Today’s research is tomorrow’s healthcare”. \nPlease refer to the Call Text of the JTC2024 for further information and definitions. \nImportant dates: \n\nOpening of the online submission tool: 12 January 2024\nInformation day introducing the JTC2024 to the research community: January 15\, 2024\, 14:00-16:00 (CET) (registration link will be available soon)\nSubmission deadline for pre-proposals: 05 March 2024\, 17:00 CET\nSubmission deadline for full-proposals: 20 June 2024\, 17:00 CEST\n\n  \nPara ampliar esta información\, o para cualquier otra consulta\, no dudes en contactar con Elena Portero (eportero.iacs@aragon.es) \nCall text  \n\nGuidelines for applicants\n\nPre-proposal form\n\n\n\n\n\nSPAIN (CFN):\nAdditional document for CFN proposals (DOC) (to be sent to CFN in parallel to the pre-proposal submission).\n\n\nFurther information
URL:https://www.iacs.es/evento/ep-permed-joint-transnational-call-2024/
LOCATION:San Juan Bosco\, 13\, Zaragoza\, Zaragoza\, 50009\, España
CATEGORIES:Convocatoria internacional
GEO:41.64381;-0.9024
X-APPLE-STRUCTURED-LOCATION;VALUE=URI;X-ADDRESS=San Juan Bosco 13 Zaragoza Zaragoza 50009 España;X-APPLE-RADIUS=500;X-TITLE=San Juan Bosco\, 13:geo:-0.9024,41.64381
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20240301T080000
DTEND;TZID=Europe/Madrid:20240416T170000
DTSTAMP:20260417T183848
CREATED:20240301T092137Z
LAST-MODIFIED:20240301T114258Z
UID:10002033-1709280000-1713286800@www.iacs.es
SUMMARY:Announcement Of The Second Joint Transnational Call
DESCRIPTION:THCS launches its second Joint Transnational Call (JTC) for proposals aiming to support the implementation of innovative person-centred health and care models addressing prevention strategies\, with the key help of existing IT and digital technologies and services. More than 30 funding agencies participate with an indicative budget of more than 34 million €. \n\n\n\n\n\n\n\nFebruary 12\, 2024: Pre-announcement of the Innovate to Prevent call\nFebruary 23\, 2024: Publication of the call\n15:00-16:30 CET March 12\, 2024: JTC 2024 Information Webinar\nApril 16\, 2024  (14:00 CEST): Deadline for obligatory Intent to Apply submission\nMay 14\, 2024  (14:00 CEST): Deadline for proposal submission\nAugust 26\, 2024: Deadline for coordinators to send their rebuttal letters\nSeptember 9-11\, 2024: PRP Meeting\nSeptember 16-27\, 2024: Ethical Evaluation of the selected proposals\nOctober 2024: Final funding recommendation announced to applicants\nEnd of 2024/early 2025: Expected scientific start of funded projects\n\n  \nInformation and application \n\nCall text\nGuidance for applicants PDF \n\nThe Intent to Apply and the Proposal must be submitted through the online submission platform. \nAccess the online submission platform. \nCall webinars \nTHCS will offer an information webinar to introduce the JTC 2024 on Tuesday 12 of March (15:00-16:30 CET). Please check the website and social media for more information. \n\nRegister
URL:https://www.iacs.es/evento/announcement-of-the-second-joint-transnational-call/
LOCATION:Online\, San Juan Bosco\, 13\, Zaragoza\, Zaragoza\, 50009\, España
CATEGORIES:Convocatoria,Convocatoria - proyectos
GEO:41.6437186;-0.9023079
X-APPLE-STRUCTURED-LOCATION;VALUE=URI;X-ADDRESS=Online San Juan Bosco 13 Zaragoza Zaragoza 50009 España;X-APPLE-RADIUS=500;X-TITLE=San Juan Bosco\, 13:geo:-0.9023079,41.6437186
END:VEVENT
END:VCALENDAR